The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sylvia L. Asa sits on this spectrum.
This scientist: 715 publications — 82nd percentile
82% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,796 publications or more.
The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sylvia L. Asa sits on this spectrum.
This scientist: 130 D-Index — 88th percentile
88% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 217 D-Index or more.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Pathology, Thyroid and Thyroid carcinoma. Her study looks at the relationship between Endocrinology and fields such as Gene expression, as well as how they intersect with chemical problems. The various areas that Sylvia L. Asa examines in her Pathology study include Gene rearrangement and Pituitary tumorigenesis.
Her Thyroid research is mostly focused on the topic Thyroid cancer. Her Thyroid carcinoma research incorporates elements of MEDLINE, Lymph node, Thyroidectomy, Carcinoma and Metastasis. Her Adenoma research is multidisciplinary, incorporating perspectives in Somatotropic cell, Estrogen receptor, Anterior pituitary, Acromegaly and Pituitary neoplasm.
Sylvia L. Asa mainly investigates Pathology, Internal medicine, Endocrinology, Thyroid and Immunohistochemistry. She usually deals with Pathology and limits it to topics linked to Thyroid carcinoma and Metastasis. Her Internal medicine study typically links adjacent topics like Oncology.
Her research on Endocrinology frequently links to adjacent areas such as Gene expression. Her Thyroid research is multidisciplinary, incorporating elements of Differential diagnosis, Cancer and Malignancy. Her work in Pituitary tumors tackles topics such as Cancer research which are related to areas like Fibroblast growth factor receptor 2 and Carcinogenesis.
Pathology, Thyroid, Neuroendocrine tumors, Immunohistochemistry and Internal medicine are her primary areas of study. She interconnects Somatotropic cell and Endocrine pathology in the investigation of issues within Pathology. Her study in Thyroid carcinoma and Thyroid cancer is done as part of Thyroid.
Her Neuroendocrine tumors research is multidisciplinary, relying on both Pituitary carcinoma, Pituitary adenoma, Hormone, Corticotropic cell and Cushing Disease. Her Immunohistochemistry study integrates concerns from other disciplines, such as Cell type and Pathogenesis. Her research in Internal medicine intersects with topics in Gastroenterology, Endocrinology, Oncology and SDHB.
Her primary scientific interests are in Pathology, Thyroid, Neuroendocrine tumors, Immunohistochemistry and Cancer research. She combines subjects such as Human physiology, Thyroid carcinoma, MEDLINE and Endocrine pathology with her study of Pathology. Sylvia L. Asa has included themes like Cyst, Pheochromocytoma and Malignancy in her Thyroid study.
Her Neuroendocrine tumors study is concerned with the larger field of Internal medicine. Her Internal medicine research integrates issues from BRAF V600E and Histopathology. Her Immunohistochemistry research focuses on Somatotropic cell and how it relates to GATA3.
Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila
Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart
Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf
Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta
Samuel A Wells;Sylvia L Asa;Henning Dralle;Rossella Elisei
Shereen Ezzat;Sylvia L. Asa M.D.;William T. Couldwell;M.P.H. Charles E. Barr M.D.
Yuri E. Nikiforov;Raja R. Seethala;Giovanni Tallini;Zubair W. Baloch
Zubair W. Baloch M.D.;Virginia A. LiVolsi;Syl L. Asa M.D.;Juan Rosai
Tetsuo Kondo;Shereen Ezzat;Shereen Ezzat;Sylvia L. Asa;Sylvia L. Asa
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao
Scott M. Wilhelm;Tracy S. Wang;Daniel T. Ruan;James A. Lee
D J Drucker;P Erlich;S L Asa;P L Brubaker
Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira
Guido Rindi;David S. Klimstra;Behnoush Abedi-Ardekani;Sylvia L. Asa
Nestor F. Gonzalez-Cadavid;Wayne E. Taylor;Kevin Yarasheski;Indrani Sinha-Hikim
Robert C. Smallridge;Kenneth B. Ain;Kenneth B. Ain;Sylvia L. Asa;Sylvia L. Asa;Keith C. Bible
Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter
Lauren Fishbein;Lauren Fishbein;Ignaty Leshchiner;Ignaty Leshchiner;Vonn Walter;Vonn Walter;Ludmila Danilova;Ludmila Danilova
Zheng S;Cherniack Ad;Cherniack Ad;Dewal N;Moffitt Ra
If you think any of the details on this page are incorrect, let us know.
Exploring careers in medicine doesn’t just mean becoming a doctor. There are diverse options in healthcare that can be started or advanced with online degrees and bridge programs. For those interested in administrative roles, online health administration programs offer flexibility and the opportunity to enter the growing field of healthcare management.
Nursing remains a popular choice. If you want to become a licensed practical nurse, but prefer to skip entrance exams, you might consider an lpn school without teas test. Existing registered nurses aiming for advanced roles can benefit from rn to np bridge programs, which provide a streamlined path to become a nurse practitioner.
Meanwhile, those interested in the behind-the-scenes operations of healthcare can pursue careers in coding and billing. Many accredited programs are available with financial aid for medical billing and coding, lowering barriers to entry and supporting career growth.
Hokkaido University
University of Southern California
Polytechnic University of Turin
University of Toronto
National Academies of Sciences, Engineering, and Medicine
Spanish National Research Council
Sorbonne University
Institut National des Sciences Appliquées de Toulouse
Carnegie Mellon University
ETH Zurich
Sandia National Laboratories
University of Liège
Chinese Academy of Sciences
University of Calgary
Claude Bernard University Lyon 1
University of California, Davis
